Cell Source
(OTC) CLCS
Cell Source Financials at a Glance
Market Cap
$33.21M
Revenue (TTM)
$0.00
Net Income (TTM)
$4.77M
EPS (TTM)
$-0.15
P/E Ratio
-5.20
Dividend
$0.00
Beta (Volatility)
136.71 (High)
Dividend
$0.00
Beta (Volatility)
136.71 (High)
Price
$0.76
Volume
200
Open
$0.76
Price
$0.76
Volume
200
Open
$0.76
Previous Close
$0.76
Daily Range
$0.76 - $0.76
52-Week Range
$0.18 - $2.25
Dividend
$0.00
Beta (Volatility)
136.71 (High)
Price
$0.76
Volume
200
Open
$0.76
Previous Close
$0.76
Daily Range
$0.76 - $0.76
52-Week Range
$0.18 - $2.25
CLCS News
CLCS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cell Source
Industry
Biotechnology
Sector
Health CareCEO
Itamar Shimrat, MBA
Website
www.cell-source.comHeadquarters
New York City, NY 10019, US
CLCS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
8%
Return on Assets
-7%
Earnings Yield
-19.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$33.21M
Shares Outstanding
43.47M
Volume
200
Short Interest
0.00%
Avg. Volume
5.55K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.85M
EBITDA
$3.60M
Operating Cash Flow
$2.68M
Capital Expenditure
$0.00
Free Cash Flow
$2.68M
Cash & ST Invst.
$74.63K
Total Debt
$10.07M
Cell Source Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$33.21M
N/A
Market Cap/Employee
$33.21M
N/A
Employees
1
N/A
Net Income
$589.71K
+43.8%
EBITDA
$375.86K
+62.3%
Quarterly Fundamentals
Net Cash
$9.99M
-8.2%
Accounts Receivable
$50.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$10.07M
+8.8%
Return on Assets
-7.00%
N/A
Return on Invested Capital
8.07%
N/A
Free Cash Flow
$748.33K
-3.6%
Operating Cash Flow
$748.33K
-3.6%